Article -> Article Details
Title | Respiratory Therapeutic Devices Market 2021 | Status and Forecast (2017-2023) |
---|---|
Category | Fitness Health --> Addictions |
Meta Keywords | Respiratory Therapeutic Devices Market |
Owner | vinit |
Description | |
Respiratory
Therapeutic Devices Market Overview Market Research Future (MRFR) studied the Global Respiratory
Therapeutic Devices Market can expand at 10.8% CAGR by 2023. COVID 19
has created a significant demand for respiratory therapeutic devices that is
observed as the chief drivers for the market. Moreover, the increase in cases
of cardiopulmonary diseases, such as asthma, chronic obstructive pulmonary
diseases (COPD), cystic fibrosis, and acute bronchitis among others are
observed due to season change and the existing virus. Thus, the demand for effective treatment and control of such
malaise is increasing, which, in turn, is creating need for respiratory
therapeutic devices. The escalation in their sales can cause the respiratory
devices market to expand in the near future. The availability of different
solutions to treat several types of respiratory malaise can be critical to the
respiratory devices market, as suggested by MRFR findings. Respiratory
Therapeutic Devices Market Segmentation The segment evaluation of the global respiratory therapeutic
devices market is done by application, product, technology, and end users. The product-based segment of the respiratory therapeutic
devices market are capnography, nebulizers, and humidifiers oxygen
concentrators among others. The nebulizers sub-segments are human-powered
nebulizer, and soft mist inhaler among others. The capnography segments are
side-stream capnography, and main-stream capnography among others. The gradual
increase in sales of nebulizer can support the expansion of the respiratory
device market. The technology-based segment of the respiratory therapeutic
device market are HEPA filtration, electrostatic filtration, microsphere
separation, and hollow fiber filtration among others. The HEPA infiltration
segment can win considerable profit for the respiratory therapeutic device
market. The application-based segments of the respiratory
therapeutic device market are chronic obstructive pulmonary disease (COPD),
asthma, and cystic fibrosis among others. The growing prevalence of asthma and
COPD can contribute to the respiratory device market growth. The end users-based segments of the respiratory therapeutic
device market are retail pharmacies, hospitals & clinics, and home care
among others. Recently, the hospital segment, followed by the home care segment
can earn gain traction. Respiratory
Therapeutic Devices Market Regional Analysis COVID 19 has penetrated corners of the Americas creating a
huge requirement for respiratory therapeutic devices to treat cardiopulmonary
diseases. This can contribute to the expansion of the respiratory therapeutic
device market in the North America region. In addition, the existence of
several reputed developers in the region can promote the expansion of the
regional market. The increase in healthcare expenditure by the regional
governments can fuel the rise of the respiratory therapeutic device market. In Europe, the respiratory therapeutic devices market can
secure the second largest share of the worldwide market due to the existence of
the healthcare infrastructure base. Increase in support from governments for
funding big research & development projects to introduce effective
solutions can promote the growth of EU market in the near future. In Asia
Pacific, the market is expected to be the fastest growing as the COVID 19
patient populace expands. China is observed to play a pivotal role in the
revenue generation of APAC respiratory therapeutic device market. In Middle
East & Africa, the respiratory therapeutic devices market is also observed
to surge to the penetration of effective solutions to treat the pandemic
afflicted. Respiratory
Therapeutic Devices Market Key Players Rotech Healthcare Inc. (U.S.), Masimo. (U.S.), BD. (U.S.),
F. Hoffmann-La Roche Ltd (Europe), Smiths Group Plc. (U.S.), Bayer AG (Europe),
Acare Technology (Asia Pacific), and Chart Industries (U.S.), among others are
some well-known companies that are operating in the respiratory therapeutic
device profiled by MRFR. |